Venous Thrombosis Flashcards

1
Q

What will an arterial thrombotic event lead to?

A

MI
Stroke
Peripheral - critical limb ischaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What will a venous thrombosis lead to?

A

DVT

PE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe an arterial thrombus?

A

Due to high pressure system and formation of atherosclerotic plaque
Plaque rupture leads to platelet aggregation and soft plug forming
PRIMARY HAEMOSTASIS
Platelet rich thrombus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is an arterial thrombus treated?

A

Aspirin
Clopidogrel
Modify risk factors for atherosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe a venous thrombosis?

A

Low pressure system
Platelets NOT activated
SECONDARY HAEMOSTASIS
Fibrin rich clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the treatment for a venous thrombosis?

A

Warfarin
Heparin
DOACs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is virchow’s triad?

A

Stasis
Vessel wall abnormality
Hypercoagulability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the single biggest risk factor for a venous clot?

A

A previous clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe a DVT affected leg

A

Hot
Swollen tender
Pitting oedema
DDx; cellulitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe a PE

A
Pleuritic chest pain 
CV collapse 
Death
Hypoxia
Right heart strain 
ECG; right axis deviation (negative lead 1, positive aVF), tachycardic 
Rarely; S1Q3T3
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the risk of VTE?

A

1/1000 per annum
Young adults; 1/10,000 per annum
Elderly 1/100 per annum
Lifetime risk is 2.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are risk factors for increased stasis in VTE risk?

A
Age
Marked obesity
Pregnancy
Previous DVT/PE 
Trauma/ surgery 
Malignancy
Paralysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are risk factors for VTE that fall under vessel wall?

A

Age; decreased collagen

Previous DVT/ PE; damage to valves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the risk factors fro VTE that fall under hypercoaguability?

A
Age
Pregnancy
Puerperium
Oestrogen therapy 
Trauma/ surgery 
Malignancy
Infection 
Thrombophilia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why are the hypercoagulable states associated with increased risk of VTE?

A

Release of tissue factor
Increased VWF
Increased factor 8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is a thrombophilia?

A

Familial or acquired disorder of haemostatic mechanism which is likely to predispose to thrombosis

17
Q

What are the mechanisms of thrombophilia?

A

Increased coagulation activity; platelet plug formation, fibrin clot formation
Decreased fibrinolytic activity
Decreased anticoag activity

18
Q

What is the most common mechanism for thrombophilia?

A

Decreased anticoag activity

19
Q

What will anti-thrombin act on?

A

TF/ factor 7a
5/10a
8/9a
Thrombin

20
Q

Can you have a deficiency in anti-thrombin?

A

Yes

21
Q

What is factor 5 leiden diseaes?

A

COMMONEST thrombophilia

Change in factor 5 that means protein C and S can’t turn it off

22
Q

What are the different types of hereditary thrombophilias?

A
Factor 5 leiden - 5 fold increase
Prothrombin 20210 mutation - 2 fold increase 
Antithrombin deficiency
Protein C deficiency
Protein S deficiency
23
Q

In what cohort of people should you consider hereditary thrombophilia screening?

A
Venous thrombosis <45 years old 
Recurrent venous thrombosis
Unusual venous thrombosis
Family history of venous thrombosis
Family history of thrombophilia
24
Q

What is the management of a hereditary thrombophilia?

A

Avoidance of risk
Short term prophylaxis at time of high risk e.g. planned surgery
Short term anticoagulation to treat thrombotic events
Long term anticoag for RECURRENT thrombotic events

25
Q

How can the risk of recurrent thrombosis be assessed?

A

Clinical history much more important than results of thrombophilia screening
History of previous thrombosis
Spontaneous thrombosis rather that acquired transient risk factor
Family history
Thrombophilia screen results

26
Q

What is the commonest acquired thrombophilia?

A

Antiphospholipid antibody syndrome

27
Q

What are the features of APS?

A

Recurrent arterial AND venous thrombosis
Recurrent foetal loss
Mild thrombocytopenia

28
Q

What is the pathogenesis of APS?

A

Abs lead to conformational change in beta-2 glycoprotein 1 which leads to activation of both primary and secondary haemostasis and vessel wall abnormalities

29
Q

What will APS do to the screening fibrin clot tests?

A
Increased APTT (same result as heparin) 
Lupus anticoagulant interferes with assay prolonging APTT even though they are prone to clots and therefore would expect a short APTT
30
Q

What will prolong the APTT?

A

Haemophilia
Heparin treatment
APS
Mixed factor abnormalities

31
Q

What are conditions associated with antiphospholipid antibodies?

A
Autoimmune disorders
Lymphoproliferative disorders
Viral infections; EBV
Drugs
Primary APS
32
Q

What is the treatment of APS?

A

Activation of both primary (arterial) and secondary (venous) haemostasis
Need to treat the problem they have; arterial clots = aspirin, venous clots = warfarin

33
Q

Why is warfarin particularly good in APS?

A

Has action on venous and arterial system

APS is the only condition where warfarin is indicated in place of DOACs